Related references
Note: Only part of the references are listed.Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Jeanne Tie et al.
GUT (2019)
Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study
Lauren E. Rosen et al.
MODERN PATHOLOGY (2018)
Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
Jesse J. Salk et al.
NATURE REVIEWS GENETICS (2018)
A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy
Dina Mönch et al.
Oncotarget (2018)
Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression
Kathrin Oehl et al.
FRONTIERS IN ONCOLOGY (2018)
Non-blood circulating tumor DNA detection in cancer
Muyun Peng et al.
ONCOTARGET (2017)
Temporal and spatial heterogeneity of programmed cell death 1-Ligand 1 expression in malignant mesothelioma
Simone B. S. P. Terra et al.
ONCOIMMUNOLOGY (2017)
Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesothelioma
Kazuma Kiyotani et al.
ONCOIMMUNOLOGY (2017)
Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types
Yongqian Shu et al.
SCIENTIFIC REPORTS (2017)
Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing
Satu Maki-Nevala et al.
LUNG (2016)
c-Met expression and MET amplification in malignant pleural mesothelioma
Melanie C. Bois et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2016)
Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations
Brandon S. Sheffield et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration
Alain C. Borczuk et al.
CANCER BIOLOGY & THERAPY (2016)
The impact of hypoxia and its modification of the outcome of radiotherapy
Michael R. Horsman et al.
JOURNAL OF RADIATION RESEARCH (2016)
The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing
Marieke Hylebos et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
Gerard Zalcman et al.
LANCET (2016)
Genomic Landscape of Malignant Mesotheliomas
Shumei Kato et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma
Mayura Meerang et al.
MOLECULAR ONCOLOGY (2016)
Divergent clonal selection dominates medulloblastoma at recurrence
A. Sorana Morrissy et al.
NATURE (2016)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Raphael Bueno et al.
NATURE GENETICS (2016)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
An Integrated Analysis of the Genome-Wide Profiles of DNA Methylation and mRNA Expression Defining the Side Population of a Human Malignant Mesothelioma Cell Line
Myung-Chul Kim et al.
JOURNAL OF CANCER (2016)
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Nicholas McGranahan et al.
CANCER CELL (2015)
A Comprehensive Genome-Based Mutational Analysis by Next Generation Sequencing Technology in Patients With Malignant Pleural and Peritoneal Mesothelioma
G. Ugurluer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma
Elizabeth H. Baldini et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2015)
Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma A Retrospective Study
Marco Lo Iacono et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma A Review of 12 Years' Experience
Isabelle Opitz et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT
Roslyn J. Francis et al.
LUNG CANCER (2015)
Second line therapy in malignant pleural mesothelioma: A systematic review
Wieneke A. Buikhuisen et al.
LUNG CANCER (2015)
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity
Bartlomiej Waclaw et al.
NATURE (2015)
Sarcomatoid differentiation during progression of malignant pleural mesothelioma
B Vrugt et al.
ZENTRALBLATT FUR CHIRURGIE (2015)
Mesothelioma treatment: Are we on target? A review
Birgitta I. Hiddinga et al.
JOURNAL OF ADVANCED RESEARCH (2015)
Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma
Guangwu Guo et al.
CANCER RESEARCH (2015)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
PI3K/mTOR Signaling in Mesothelioma Patients Treated with Induction Chemotherapy Followed by Extrapleural Pneumonectomy
Byron K. Y. Bitanihirwe et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Evaluation of clonal origin of malignant mesothelioma
Sabahattin Comertpay et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Identification of actionable mutations in malignant pleural mesothelioma
Takehito Shukuya et al.
LUNG CANCER (2014)
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer
Luping Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
Irina M. Shapiro et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
EGF-induced adipose tissue mesothelial cells undergo functional vascular smooth muscle differentiation
C. C. Lachaud et al.
CELL DEATH & DISEASE (2014)
Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
Vanessa Almendro et al.
CELL REPORTS (2014)
Diagnostic Usefulness of p16/CDKN2A FISH in Distinguishing Between Sarcomatoid Mesothelioma and Fibrous Pleuritis
Di Wu et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma
Yasunori Enomoto et al.
PATHOLOGY INTERNATIONAL (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
Pleural mesothelioma side populations have a precursor phenotype
Claudia Frei et al.
CARCINOGENESIS (2011)
Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: An exploratory analysis
Roy Sidi et al.
EUROPEAN JOURNAL OF CANCER (2011)
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew Bott et al.
NATURE GENETICS (2011)
Second Surgery for Recurrence of Malignant Pleural Mesothelioma After Extrapleural Pneumonectomy
Leonardo Politi et al.
ANNALS OF THORACIC SURGERY (2010)
Somatic EGFR Mutation and Gene Copy Gain as Predictive Biomarkers for Response to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Issa J. Dahabreh et al.
CLINICAL CANCER RESEARCH (2010)
Characterization of side population cells in human malignant mesothelioma cell lines
Kiyonori Kai et al.
LUNG CANCER (2010)
Genomic events associated with progression of pleural malignant mesothelioma
Sergey V. Ivanov et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group study
Linda L. Garland et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
EGFR overexpression in malignant pleural mesothelioma - An immunohistochemical and molecular study with clinico-pathological correlations
A Destro et al.
LUNG CANCER (2006)
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma
R Jagadeeswaran et al.
CANCER RESEARCH (2006)
Gefitinib in patients with malignant mesothelioma: A phase II study by the cancer and leukemia group B
R Govindan et al.
CLINICAL CANCER RESEARCH (2005)
Pathogenesis of malignant pleural mesothelioma
MC Jaurand et al.
RESPIROLOGY (2005)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
